Interferon γ: a master cytokine in microglia-mediated neural network dysfunction and neurodegeneration

Oliver Kann1, Fadi Almouhanna2, Bruno Chausse2

  • 1Institute of Physiology and Pathophysiology, University of Heidelberg, D-69120 Heidelberg, Germany; Interdisciplinary Center for Neurosciences (IZN), University of Heidelberg, D-69120 Heidelberg, Germany.

Trends in Neurosciences
|October 25, 2022
PubMed

Insights

Interferon gamma (IFN-γ) uniquely activates microglia, causing cognitive decline and neuronal death. Targeting these activated brain cells may benefit neuroinflammatory diseases like multiple sclerosis and Alzheimer's.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Interferon gamma (IFN-γ) was traditionally viewed as a pro-inflammatory mediator for microglia during infections.
  • Emerging research indicates a more complex, unique role for IFN-γ in microglial activation and brain function.

Purpose of the Study:

  • To elucidate the specific functions of IFN-γ in microglial activation beyond simple pro-inflammatory boosting.
  • To investigate the consequences of IFN-γ-mediated microglial priming on neuronal networks and cognitive function.

Main Methods:

  • In situ slice cultures and in vivo studies were employed to observe microglial responses.
  • Analysis of microglial proliferation, synapse elimination, nitric oxide release, and network activity was performed.

Main Results:

  • IFN-γ priming induces microgliosis, enhances synapse elimination, and impairs synaptic transmission and cognitive functions.
  • IFN-γ drives Toll-like receptor-activated microglia towards neurotoxic phenotypes, causing oxidative stress, network dysfunction, and neuronal death.

Conclusions:

  • IFN-γ plays a critical role in modulating microglial activity, leading to neurotoxic effects and cognitive impairment.
  • Pharmacological targeting of activated microglia is a potential therapeutic strategy for conditions with elevated IFN-γ, such as encephalitis, multiple sclerosis, and Alzheimer's disease.